H2N2V1, Pmc, Corpus, indexHead, AutAff.i

Eiamudomkan A < Eichelberger M < Eichenberger E

Author's uniq id: Eichelberger M
Total number of names:
Total number of records with affiliations: 58

M Eichelberger

NONE (BIBLIO)

000065
000956
000A67
000B20
000C55
000D57
000E48

M. C. Eichelberger

NONE (BIBLIO)

000004
000D45
000D60
000D61
000D86

M. Eichelberger

NONE (BIBLIO)

000044
000E28
000E35
000E40

M.C. Eichelberger

NONE (BIBLIO)

000995
000D76
000D78
000D79
000E22
000E28
000E35
000E40

MC Eichelberger

NONE (BIBLIO)

000009
000080
000206
000238
000240
000501
000592
000997
000A21
000A39
000A67
000B13
000B15
000B37
000B75
000B93
000C55
000C56
000C63
000D08
000D57
000D68
000D93
000E43
000E48

Maryna C. Eichelberger

Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA	000784
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA	000804
Division of Biological Standards and Quantity Control, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA	000838
Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration , Silver Spring, Maryland ;	000A35
	000070
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration , Bethesda, MD 20892;	000753
Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA	000E48

Maryna Eichelberger

Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA	000855
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA	000C55

<g><k>Eichelberger M</k>
<l><g><k>M Eichelberger</k>
<l><g><k><nlm:aff>NONE (BIBLIO)</nlm:aff>
</k>
<l><i>000065</i>
<i>000956</i>
<i>000A67</i>
<i>000B20</i>
<i>000C55</i>
<i>000D57</i>
<i>000E48</i>
</l>
<n>7</n>
<t>7</t>
</g>
</l>
<n>1</n>
<t>7</t>
</g>
<g><k>M. C. Eichelberger</k>
<l><g><k><nlm:aff>NONE (BIBLIO)</nlm:aff>
</k>
<l><i>000004</i>
<i>000D45</i>
<i>000D60</i>
<i>000D61</i>
<i>000D86</i>
</l>
<n>5</n>
<t>5</t>
</g>
</l>
<n>1</n>
<t>5</t>
</g>
<g><k>M. Eichelberger</k>
<l><g><k><nlm:aff>NONE (BIBLIO)</nlm:aff>
</k>
<l><i>000044</i>
<i>000E28</i>
<i>000E35</i>
<i>000E40</i>
</l>
<n>4</n>
<t>4</t>
</g>
</l>
<n>1</n>
<t>4</t>
</g>
<g><k>M.C. Eichelberger</k>
<l><g><k><nlm:aff>NONE (BIBLIO)</nlm:aff>
</k>
<l><i>000995</i>
<i>000D76</i>
<i>000D78</i>
<i>000D79</i>
<i>000E22</i>
<i>000E28</i>
<i>000E35</i>
<i>000E40</i>
</l>
<n>8</n>
<t>8</t>
</g>
</l>
<n>1</n>
<t>8</t>
</g>
<g><k>MC Eichelberger</k>
<l><g><k><nlm:aff>NONE (BIBLIO)</nlm:aff>
</k>
<l><i>000009</i>
<i>000080</i>
<i>000206</i>
<i>000238</i>
<i>000240</i>
<i>000501</i>
<i>000592</i>
<i>000997</i>
<i>000A21</i>
<i>000A39</i>
<i>000A67</i>
<i>000B13</i>
<i>000B15</i>
<i>000B37</i>
<i>000B75</i>
<i>000B93</i>
<i>000C55</i>
<i>000C56</i>
<i>000C63</i>
<i>000D08</i>
<i>000D57</i>
<i>000D68</i>
<i>000D93</i>
<i>000E43</i>
<i>000E48</i>
</l>
<n>25</n>
<t>25</t>
</g>
</l>
<n>1</n>
<t>25</t>
</g>
<g><k>Maryna C. Eichelberger</k>
<l><g><k><nlm:aff id="A2">Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA</nlm:aff>
</k>
<l><i>000784</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><nlm:aff id="A5">Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA</nlm:aff>
</k>
<l><i>000804</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><nlm:aff id="A6">Division of Biological Standards and Quantity Control, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA</nlm:aff>
</k>
<l><i>000838</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><nlm:aff id="AF0003"><institution>Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration</institution>
,<addr-line>Silver Spring, Maryland</addr-line>
;</nlm:aff>
</k>
<l><i>000A35</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><nlm:aff id="a2"></nlm:aff>
</k>
<l><i>000070</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><nlm:aff id="aff1">Division of Viral Products, Center for Biologics Evaluation and Research,<institution>Food and Drug Administration</institution>
, Bethesda, MD 20892;</nlm:aff>
</k>
<l><i>000753</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><nlm:aff id="aff5"><addr-line>Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</nlm:aff>
</k>
<l><i>000E48</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>7</n>
<t>7</t>
</g>
<g><k>Maryna Eichelberger</k>
<l><g><k><nlm:aff id="A2">Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA</nlm:aff>
</k>
<l><i>000855</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><nlm:aff id="aff4"><addr-line>Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</nlm:aff>
</k>
<l><i>000C55</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>7</n>
<t>58</t>
</g>

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021

	Serveur d'exploration H2N2
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration H2N2